CD8A and neoplasm: The present study scored stromal, intratumoral, and global TIL (as a percentage of the defined area), TLS as well as CD3+, CD4+, CD8+, and CD20+ TIL as a percentage of the defined stromal, tumor, and global areas (Table S1 in Supplementary Material).